These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17581897)

  • 21. Nonpalpable, probably benign lesions: role of follow-up mammography.
    Varas X; Leborgne F; Leborgne JH
    Radiology; 1992 Aug; 184(2):409-14. PubMed ID: 1620838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of the results of 137 subclinical breast lesions excisions. Value of ultrasonography in the early diagnosis of breast cancer].
    Jacob D; Brombart JC; Muller C; Lefèbvre C; Massa F; Depoerck A
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):27-31. PubMed ID: 9091540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of solid palpable masses assessed as BI-RADS 3 or 4A: a retrospective review.
    Patterson SK; Neal CH; Jeffries DO; Joe A; Klein K; Bailey J; Pinsky R; Paramagul C; Watcharotone K
    Breast Cancer Res Treat; 2014 Sep; 147(2):311-6. PubMed ID: 25151294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of US-guided fine-needle aspiration with on-site cytopathologic evaluation in management of nonpalpable breast lesions.
    Buchbinder SS; Gurell DS; Tarlow MM; Salvatore M; Suhrland MJ; Kader K
    Acad Radiol; 2001 Apr; 8(4):322-7. PubMed ID: 11293780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up.
    Gordon PB; Gagnon FA; Lanzkowsky L
    Radiology; 2003 Oct; 229(1):233-8. PubMed ID: 14519878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic assessment of non-palpable probably benign breast masses at sonography: can instant intervention be avoided and is follow-up adequate?
    Yücesoy C; Oktay NA; Oztürk E; Oktay M; Hücümenoğlu S; Alper M; Hekimoğlu B
    JBR-BTR; 2010; 93(5):242-6. PubMed ID: 21179983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of 6-month follow-up imaging after a concordant benign breast biopsy result.
    Salkowski LR; Fowler AM; Burnside ES; Sisney GA
    Radiology; 2011 Feb; 258(2):380-7. PubMed ID: 21079199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radiology of nonpalpable breast lesions].
    Vega A; Nava E; Ortega E; Garijo F
    Rev Med Univ Navarra; 1995; 39(4):11-7. PubMed ID: 9499837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid breast lesions: diagnosis with US-guided fine-needle aspiration biopsy.
    Gordon PB; Goldenberg SL; Chan NH
    Radiology; 1993 Nov; 189(2):573-80. PubMed ID: 8210392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonography as adjunct to mammography in the evaluation of breast tumors.
    Skaane P
    Acta Radiol Suppl; 1999; 420():1-47. PubMed ID: 10693544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study.
    Lehman CD; Isaacs C; Schnall MD; Pisano ED; Ascher SM; Weatherall PT; Bluemke DA; Bowen DJ; Marcom PK; Armstrong DK; Domchek SM; Tomlinson G; Skates SJ; Gatsonis C
    Radiology; 2007 Aug; 244(2):381-8. PubMed ID: 17641362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign versus malignant solid breast masses: US differentiation.
    Rahbar G; Sie AC; Hansen GC; Prince JS; Melany ML; Reynolds HE; Jackson VP; Sayre JW; Bassett LW
    Radiology; 1999 Dec; 213(3):889-94. PubMed ID: 10580971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous excisional biopsy of palpable breast masses under ultrasound visualization.
    Vargas HI; Vargas MP; Gonzalez K; Burla M; Khalkhali I
    Breast J; 2006; 12(5 Suppl 2):S218-22. PubMed ID: 16959005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The diagnostic role of breast echography].
    Ciatto S; Rosselli del Turco M; Catarzi S; Morrone D; Bonardi R
    Radiol Med; 1994 Sep; 88(3):221-4. PubMed ID: 7938725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probably Benign Solid Breast Lesions on Ultrasound: Need for Biopsy Reassessed.
    Fatima K; Masroor I; Khanani S
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3467-3471. PubMed ID: 30583671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopsy versus conservative management of sonographically benign-appearing solid breast masses in adolescents.
    Jawahar A; Vade A; Ward K; Okur G; Subbaiah P
    J Ultrasound Med; 2015 Apr; 34(4):617-25. PubMed ID: 25792577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of ultrasonography to the differential diagnosis of breast cancer.
    Ciatto S; Rosselli del Turco M; Catarzi S; Morrone D
    Neoplasma; 1994; 41(6):341-5. PubMed ID: 7870218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years.
    Osako T; Iwase T; Takahashi K; Iijima K; Miyagi Y; Nishimura S; Tada K; Makita M; Akiyama F; Sakamoto G; Kasumi F
    Breast Cancer; 2007; 14(3):255-9. PubMed ID: 17690501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.